日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

在用 MEK 抑制剂治疗的 KRAS 突变肿瘤中,SHP2 抑制剂可克服 RTK 介导的通路再激活

Hengyu Lu #, Chen Liu #, Roberto Velazquez, Hongyun Wang, Lukas Manuel Dunkl, Malika Kazic-Legueux, Anne Haberkorn, Eric Billy, Eusebio Manchado, Saskia M Brachmann, Susan E Moody, Jeffrey A Engelman, Peter S Hammerman, Giordano Caponigro, Morvarid Mohseni, Huai-Xiang Hao

CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions

CRISPR 筛选可全面评估癌症的脆弱性,但会对高度扩增的基因组区域产生假阳性结果

Diana M Munoz, Pamela J Cassiani, Li Li, Eric Billy, Joshua M Korn, Michael D Jones, Javad Golji, David A Ruddy, Kristine Yu, Gregory McAllister, Antoine DeWeck, Dorothee Abramowski, Jessica Wan, Matthew D Shirley, Sarah Y Neshat, Daniel Rakiec, Rosalie de Beaumont, Odile Weber, Audrey Kauffmann, E

The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity

酪氨酸磷酸酶 PTPN14 是 YAP 活性的负调节剂

Chrysiis Michaloglou, Waltraut Lehmann, Typhaine Martin, Clara Delaunay, Andreas Hueber, Louise Barys, Honglin Niu, Eric Billy, Markus Wartmann, Moriko Ito, Christopher J Wilson, Mary Ellen Digan, Andreas Bauer, Hans Voshol, Gerhard Christofori, William R Sellers, Francesco Hofmann, Tobias Schmelzle

Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor

缺乏质子传感受体 GPR4 的小鼠的病理性血管生成和肿瘤生长减少

Lorenza Wyder, Thomas Suply, Bérangère Ricoux, Eric Billy, Christian Schnell, Birgit U Baumgarten, Sauveur Michel Maira, Claudia Koelbing, Mireille Ferretti, Bernd Kinzel, Matthias Müller, Klaus Seuwen, Marie-Gabrielle Ludwig